FI112322B - Menetelmä dekspantenolia sisältävän, steroidihormonien transdermaaliseen antoon tarkoitetun laastarin valmistamiseksi - Google Patents

Menetelmä dekspantenolia sisältävän, steroidihormonien transdermaaliseen antoon tarkoitetun laastarin valmistamiseksi Download PDF

Info

Publication number
FI112322B
FI112322B FI951169A FI951169A FI112322B FI 112322 B FI112322 B FI 112322B FI 951169 A FI951169 A FI 951169A FI 951169 A FI951169 A FI 951169A FI 112322 B FI112322 B FI 112322B
Authority
FI
Finland
Prior art keywords
melt
weight
dexpanthenol
med
adhesive
Prior art date
Application number
FI951169A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951169A0 (fi
FI951169A (fi
Inventor
Michael Roreger
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI951169A0 publication Critical patent/FI951169A0/fi
Publication of FI951169A publication Critical patent/FI951169A/fi
Application granted granted Critical
Publication of FI112322B publication Critical patent/FI112322B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J123/00—Adhesives based on homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Adhesives based on derivatives of such polymers
    • C09J123/02—Adhesives based on homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Adhesives based on derivatives of such polymers not modified by chemical after-treatment
    • C09J123/04—Homopolymers or copolymers of ethene
    • C09J123/08—Copolymers of ethene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/04—Macromolecular compounds according to groups C08L7/00 - C08L49/00, or C08L55/00 - C08L57/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
FI951169A 1992-09-12 1995-03-13 Menetelmä dekspantenolia sisältävän, steroidihormonien transdermaaliseen antoon tarkoitetun laastarin valmistamiseksi FI112322B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4230588 1992-09-12
DE4230588A DE4230588C1 (de) 1992-09-12 1992-09-12 Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
PCT/EP1993/002182 WO1994006436A1 (de) 1992-09-12 1993-08-16 Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
EP9302182 1993-08-16

Publications (3)

Publication Number Publication Date
FI951169A0 FI951169A0 (fi) 1995-03-13
FI951169A FI951169A (fi) 1995-03-13
FI112322B true FI112322B (fi) 2003-11-28

Family

ID=6467830

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951169A FI112322B (fi) 1992-09-12 1995-03-13 Menetelmä dekspantenolia sisältävän, steroidihormonien transdermaaliseen antoon tarkoitetun laastarin valmistamiseksi

Country Status (25)

Country Link
US (1) US5662923A (ja)
EP (1) EP0659081B1 (ja)
JP (1) JPH08508238A (ja)
KR (1) KR100297548B1 (ja)
AT (1) ATE163854T1 (ja)
AU (1) AU683017B2 (ja)
CZ (1) CZ283589B6 (ja)
DE (2) DE4230588C1 (ja)
DK (1) DK0659081T3 (ja)
ES (1) ES2118249T3 (ja)
FI (1) FI112322B (ja)
GR (1) GR3026503T3 (ja)
HR (1) HRP931107B1 (ja)
HU (1) HUT75779A (ja)
IL (1) IL106512A (ja)
MY (1) MY110531A (ja)
NO (1) NO308235B1 (ja)
NZ (1) NZ255352A (ja)
PH (1) PH31298A (ja)
PL (1) PL174605B1 (ja)
SI (1) SI9300471A (ja)
SK (1) SK280493B6 (ja)
WO (1) WO1994006436A1 (ja)
YU (1) YU58393A (ja)
ZA (1) ZA936687B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19720777A1 (de) * 1997-05-17 1998-11-19 Barbara Panzner Mehrphasenauflagesystem mit Verpackung
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19834007C1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
US6241998B1 (en) 1999-02-02 2001-06-05 Acutek International Dermatological patch
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
DE60022174T2 (de) * 1999-04-01 2006-02-16 Alza Corp., Mountain View Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
WO2000074661A2 (en) * 1999-06-05 2000-12-14 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
WO2001052823A2 (en) * 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10118282A1 (de) 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
BRPI0312007B1 (pt) 2002-06-25 2015-04-14 Acrux Dds Pty Ltd Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição
DE10256774A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
JP2004277345A (ja) * 2003-03-17 2004-10-07 Daikyo Yakuhin Kogyo Kk 硬膏剤及びその製造法
DE202004000552U1 (de) * 2004-01-15 2004-04-01 Ivoclar Vivadent Ag Mittel zum Bleichen von Zähnen
DE102008006210A1 (de) * 2008-01-26 2009-07-30 Lts Lohmann Therapie-Systeme Ag Kosmetisches Fixierpflaster
GB2502554B (en) * 2012-05-30 2016-02-03 Henkel Ireland Ltd Primers
CN103720677A (zh) * 2014-01-15 2014-04-16 桂林安和药业有限公司 可重复揭贴且可重复涂布药物的贴膏
US10226419B2 (en) * 2014-09-08 2019-03-12 ProMed Pharma, LLC Methods for manufacturing implants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615012A (ja) * 1984-06-11 1986-01-10 Dai Ichi Seiyaku Co Ltd 貼付剤
WO1986001402A1 (en) * 1984-09-05 1986-03-13 Schering Aktiengesellschaft Means for handling androgenization phenomena and use of antiandrogens for the production thereof
JPH0816053B2 (ja) * 1986-12-04 1996-02-21 大正製薬株式会社 貼付剤の製造方法
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
CH674618A5 (ja) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster

Also Published As

Publication number Publication date
JPH08508238A (ja) 1996-09-03
KR100297548B1 (ko) 2001-10-24
KR950703343A (ko) 1995-09-20
NZ255352A (en) 1996-08-27
HUT75779A (en) 1997-05-28
PL307786A1 (en) 1995-06-26
PL174605B1 (pl) 1998-08-31
IL106512A (en) 1997-07-13
PH31298A (en) 1998-07-06
EP0659081A1 (de) 1995-06-28
IL106512A0 (en) 1993-11-15
SK32795A3 (en) 1995-07-11
NO950931D0 (no) 1995-03-10
US5662923A (en) 1997-09-02
ES2118249T3 (es) 1998-09-16
WO1994006436A1 (de) 1994-03-31
AU683017B2 (en) 1997-10-30
NO308235B1 (no) 2000-08-21
SK280493B6 (sk) 2000-03-13
SI9300471A (en) 1994-03-31
YU58393A (sh) 1996-07-24
DK0659081T3 (da) 1999-01-04
FI951169A0 (fi) 1995-03-13
DE59308256D1 (de) 1998-04-16
CZ283589B6 (cs) 1998-05-13
MY110531A (en) 1998-07-31
AU4948493A (en) 1994-04-12
FI951169A (fi) 1995-03-13
NO950931L (no) 1995-03-10
EP0659081B1 (de) 1998-03-11
HRP931107A2 (en) 1994-12-31
ATE163854T1 (de) 1998-03-15
HRP931107B1 (en) 1999-12-31
ZA936687B (en) 1994-04-29
HU9500729D0 (en) 1995-04-28
DE4230588C1 (de) 1993-10-07
CZ63795A3 (en) 1995-10-18
GR3026503T3 (en) 1998-07-31

Similar Documents

Publication Publication Date Title
FI112322B (fi) Menetelmä dekspantenolia sisältävän, steroidihormonien transdermaaliseen antoon tarkoitetun laastarin valmistamiseksi
US6143319A (en) Transdermal therapeutic system containing estradiol
KR100757726B1 (ko) 4-비페닐릴 아세트산 함유 진통 소염 외용 첨부제
EP2136795B1 (en) Amorphous drug transdermal systems, manufacturing methods, and stabilization
FI119358B (fi) Estradiolipitoinen laastari
FR2717689A1 (fr) Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
EP1623711B1 (en) External patch containing estrogen and/or progestogen
CZ205396A3 (en) Plaster with controlled release of estradiol
JP2001508070A (ja) ホルモン剤供給のための経皮吸収治療システム
AU768755B2 (en) Transdermal therapeutic system containing hormones and crystallization inhibitors
KR100559089B1 (ko) 호르몬의 경피 적용용 에스트라디올 함유 패치
KR100803010B1 (ko) 외용 첨부제
CA2144441C (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones
MXPA01001042A (en) Estradiol-containing patch for transdermal administration of hormones

Legal Events

Date Code Title Description
MM Patent lapsed